This study compared the Olink® Target 48 Cytokine panel head-to-head with two commonly used commercial multiplex proteomics platforms, Mesoscale Discovery (MSD) and BioRad/Luminex) as well as to Olink® Explore 1536. With this comparative study, we aimed to verify the quality of the Olink technology relative to similar products widely used in protein biomarker research. The aim is not to investigate or explain potential differences between platforms and no criticism of the other technologies involved is implied or intended.

Download the white paper here.

Download the appendix here.